COVID-19 patients with an A1C of 6.5% or higher had elevated risk for secondary respiratory infections and acute respiratory distress syndrome, according to a study in the Journal of Diabetes Investigation. Higher A1C was also tied to greater risk for in-hospital death, even after accounting for factors such as age, sex and comorbidities.